TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 40 filers reported holding TENAX THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,162,000 | -15.8% | 1,108,593 | 0.0% | 0.44% | -32.2% |
Q3 2016 | $2,568,000 | -9.5% | 1,108,593 | 0.0% | 0.66% | -19.4% |
Q2 2016 | $2,838,000 | +24.9% | 1,108,593 | 0.0% | 0.81% | -0.4% |
Q1 2016 | $2,273,000 | -37.5% | 1,108,593 | 0.0% | 0.82% | -46.5% |
Q4 2015 | $3,636,000 | +9.3% | 1,108,593 | 0.0% | 1.53% | +16.0% |
Q3 2015 | $3,326,000 | -18.7% | 1,108,593 | 0.0% | 1.32% | -17.5% |
Q2 2015 | $4,091,000 | +13.2% | 1,108,593 | 0.0% | 1.60% | +0.3% |
Q1 2015 | $3,614,000 | -15.1% | 1,108,593 | 0.0% | 1.59% | -22.4% |
Q4 2014 | $4,257,000 | -2.9% | 1,108,593 | -0.6% | 2.05% | +8.8% |
Q3 2014 | $4,384,000 | – | 1,115,497 | – | 1.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,108,593 | $3,636,000 | 1.53% |
ARMISTICE CAPITAL, LLC | 990,000 | $3,247,000 | 1.16% |
RA Capital Management | 2,389,700 | $7,838,000 | 0.78% |
Opaleye Management Inc. | 540,000 | $1,771,000 | 0.74% |
SABBY MANAGEMENT, LLC | 2,693,537 | $8,835,000 | 0.49% |
Broadfin Capital, LLC | 1,968,631 | $6,457,000 | 0.40% |
DAFNA Capital Management LLC | 79,509 | $261,000 | 0.23% |
BOURGEON CAPITAL MANAGEMENT LLC | 55,500 | $182,000 | 0.12% |
BAILARD, INC. | 60,000 | $197,000 | 0.09% |
Verition Fund Management LLC | 32,140 | $105,000 | 0.02% |